Centre for Health Informatics, Australian Institute of Health Innovation, Macquarie University, NSW 2109, Australia.
J Am Med Inform Assoc. 2023 Jun 20;30(7):1227-1236. doi: 10.1093/jamia/ocad065.
To examine the real-world safety problems involving machine learning (ML)-enabled medical devices.
We analyzed 266 safety events involving approved ML medical devices reported to the US FDA's MAUDE program between 2015 and October 2021. Events were reviewed against an existing framework for safety problems with Health IT to identify whether a reported problem was due to the ML device (device problem) or its use, and key contributors to the problem. Consequences of events were also classified.
Events described hazards with potential to harm (66%), actual harm (16%), consequences for healthcare delivery (9%), near misses that would have led to harm if not for intervention (4%), no harm or consequences (3%), and complaints (2%). While most events involved device problems (93%), use problems (7%) were 4 times more likely to harm (relative risk 4.2; 95% CI 2.5-7). Problems with data input to ML devices were the top contributor to events (82%).
Much of what is known about ML safety comes from case studies and the theoretical limitations of ML. We contribute a systematic analysis of ML safety problems captured as part of the FDA's routine post-market surveillance. Most problems involved devices and concerned the acquisition of data for processing by algorithms. However, problems with the use of devices were more likely to harm.
Safety problems with ML devices involve more than algorithms, highlighting the need for a whole-of-system approach to safe implementation with a special focus on how users interact with devices.
研究涉及机器学习(ML)启用的医疗器械的实际安全问题。
我们分析了 2015 年至 2021 年 10 月期间向美国 FDA 的 MAUDE 计划报告的 266 起涉及已批准的 ML 医疗器械的安全事件。根据现有的医疗信息技术安全问题框架,对事件进行了审查,以确定报告的问题是由于 ML 设备(设备问题)还是其使用引起的,以及问题的主要原因。还对事件的后果进行了分类。
事件描述了具有潜在伤害风险的危害(66%)、实际伤害(16%)、对医疗保健服务的影响(9%)、若非干预则可能导致伤害的近因(4%)、无伤害或后果(3%)和投诉(2%)。虽然大多数事件涉及设备问题(93%),但使用问题(7%)导致伤害的可能性是其 4 倍(相对风险 4.2;95%CI 2.5-7)。将数据输入到 ML 设备的问题是导致事件的主要原因(82%)。
关于 ML 安全的大部分知识来自案例研究和 ML 的理论限制。我们对作为 FDA 常规上市后监测一部分捕获的 ML 安全问题进行了系统分析。大多数问题涉及设备,涉及算法处理数据的获取。然而,设备使用问题更有可能造成伤害。
ML 设备的安全问题不仅涉及算法,还强调需要采用系统整体方法来实现安全,特别关注用户与设备的交互方式。